Find Tolperisone manufacturers, exporters & distributors on PharmaCompass

PharmaCompass

Synopsis

Synopsis

ACTIVE PHARMA INGREDIENTS

0

CEP/COS

0

KDMF

0

NDC API

0

VMF

REF. STANDARDS OR IMPURITIES

0

EDQM

0

USP

0

JP

FINISHED DOSAGE FORMULATIONS

0

FDA Orange Book

0

Canada

0

Australia

0

South Africa

FDF Dossiers

DRUG PRODUCT COMPOSITIONS

0RELATED EXCIPIENT COMPANIES

0EXCIPIENTS BY APPLICATIONS

PATENTS & EXCLUSIVITIES

0

US Patents

0

US Exclusivities

0

Health Canada Patents

GLOBAL SALES INFORMATION

US Medicaid

NA

Annual Reports

NA

Regulatory FDF Prices

NA

MARKET PLACE

DIGITAL CONTENT

0

Data Compilation #PharmaFlow

0

Stock Recap #PipelineProspector

0

Weekly News Recap #Phispers

Chemistry

Click the arrow to open the dropdown
read-moreClick the button for full data set
Also known as: 3644-61-9, Tolperisone hcl, Midocalm, Muscalm, Tolperisone (hydrochloride), 2,4'-dimethyl-3-piperidinopropiophenone hydrochloride
Molecular Formula
C16H24ClNO
Molecular Weight
281.82  g/mol
InChI Key
ZBUVYROEHQQAKL-UHFFFAOYSA-N
FDA UNII
8Z075K2TIG

Tolperisone
A centrally acting muscle relaxant that has been used for the symptomatic treatment of spasticity and muscle spasm. (From Martindale, The Extra Pharmacopoeia, 30th ed, p1211)
1 2D Structure

Tolperisone

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
2-methyl-1-(4-methylphenyl)-3-piperidin-1-ylpropan-1-one;hydrochloride
2.1.2 InChI
InChI=1S/C16H23NO.ClH/c1-13-6-8-15(9-7-13)16(18)14(2)12-17-10-4-3-5-11-17;/h6-9,14H,3-5,10-12H2,1-2H3;1H
2.1.3 InChI Key
ZBUVYROEHQQAKL-UHFFFAOYSA-N
2.1.4 Canonical SMILES
CC1=CC=C(C=C1)C(=O)C(C)CN2CCCCC2.Cl
2.2 Other Identifiers
2.2.1 UNII
8Z075K2TIG
2.3 Synonyms
2.3.1 MeSH Synonyms

1. Hydrochloride, Tolperisone

2. Midocalm

3. Mydeton

4. Mydocalm

5. Tolperisone

2.3.2 Depositor-Supplied Synonyms

1. 3644-61-9

2. Tolperisone Hcl

3. Midocalm

4. Muscalm

5. Tolperisone (hydrochloride)

6. 2,4'-dimethyl-3-piperidinopropiophenone Hydrochloride

7. 2-methyl-3-piperidino-1-p-tolylpropan-1-one Hydrochloride

8. Tolperisone Hydrochloride [jan]

9. 2-methyl-1-(4-methylphenyl)-3-(piperidin-1-yl)propan-1-one Hydrochloride

10. N-553

11. 2-methyl-1-(4-methylphenyl)-3-(1-piperidinyl)-1-propanone Hydrochloride

12. 3644-61-9 (hcl)

13. 8z075k2tig

14. 1-piperidino-2-methyl-3-(p-tolyl)-3-propanone Hydrochloride

15. Ncgc00094929-01

16. Dsstox_cid_25868

17. Dsstox_rid_81187

18. Dsstox_gsid_45868

19. Arantoick

20. Atmosgen

21. Besnoline

22. Isocalm

23. Kineorl

24. Metosomin

25. Abbsa

26. 2-methyl-3-(piperidin-1-yl)-1-p-tolylpropan-1-one Hydrochloride

27. 2-methyl-1-(4-methylphenyl)-3-piperidin-1-ylpropan-1-one;hydrochloride

28. Cas-3644-61-9

29. Tolperisonehydrochloride

30. Einecs 222-876-5

31. Av 650

32. Unii-8z075k2tig

33. 1-propanone, 2-methyl-1-(4-methylphenyl)-3-(1-piperidinyl)-, Hydrochloride

34. Muscalm (tn)

35. Mfcd00058211

36. Biocalm

37. Minacalm

38. Naismeritin

39. Tolfree

40. Tolisartine

41. Tolpidol

42. Ncgc00182078-02

43. Mls004773941

44. Schembl872770

45. Spectrum1501194

46. 2,4'-dimethyl-3-piperidino-propiophenone Hydrochloride

47. Chembl1395150

48. Dtxsid2045868

49. Chebi:32244

50. Propiophenone, 2,4'-dimethyl-3-piperidino-, Hydrochloride

51. Tolperisone Hydrochloride (jp17)

52. Hms1921p09

53. Pharmakon1600-01501194

54. Hy-b1139

55. Tox21_111360

56. Tox21_113139

57. Ccg-40311

58. Nsc757872

59. S4200

60. Tolperisone Hydrochloride [mi]

61. 2-methyl-1-(4-methylphenyl)-3-(1-piperidyl)propan-1-one Hydrochloride

62. Akos005167032

63. Tox21_111360_1

64. Ac-4685

65. Cs-4744

66. Ncgc00094929-02

67. Ncgc00178060-03

68. Tolperisone Hydrochloride [mart.]

69. As-12472

70. Bp-10588

71. Smr003500666

72. Tolperisone Hydrochloride [who-dd]

73. Ft-0603642

74. Ft-0675274

75. Sw219278-1

76. T1319

77. A18694

78. D01507

79. H12066

80. 644t619

81. Sr-01000872774

82. Tolperisone Hydrochloride, >=98% (hplc), Solid

83. Sr-01000872774-1

84. W-106614

85. Q27271220

86. F9995-4198

87. 2-methyl-3-(piperidin-1-yl)-1-(p-tolyl)propan-1-one Hydrochloride

88. 1-propanone, 2-methyl-1-(4-methylphenyl)-3-(1-piperidinyl)-, Hydrochloride (1:1)

2.4 Create Date
2005-06-24
3 Chemical and Physical Properties
Molecular Weight 281.82 g/mol
Molecular Formula C16H24ClNO
Hydrogen Bond Donor Count1
Hydrogen Bond Acceptor Count2
Rotatable Bond Count4
Exact Mass281.1546421 g/mol
Monoisotopic Mass281.1546421 g/mol
Topological Polar Surface Area20.3 Ų
Heavy Atom Count19
Formal Charge0
Complexity262
Isotope Atom Count0
Defined Atom Stereocenter Count0
Undefined Atom Stereocenter Count1
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count2
4 Pharmacology and Biochemistry
4.1 MeSH Pharmacological Classification

Muscle Relaxants, Central

A heterogeneous group of drugs used to produce muscle relaxation, excepting the neuromuscular blocking agents. They have their primary clinical and therapeutic uses in the treatment of muscle spasm and immobility associated with strains, sprains, and injuries of the back and, to a lesser degree, injuries to the neck. They have been used also for the treatment of a variety of clinical conditions that have in common only the presence of skeletal muscle hyperactivity, for example, the muscle spasms that can occur in MULTIPLE SCLEROSIS. (From Smith and Reynard, Textbook of Pharmacology, 1991, p358) (See all compounds classified as Muscle Relaxants, Central.)


USDMF

read-more
read-moreread-more

01

Gedeon Richter Ltd

Hungary

USDMF

arrow
AOCS Annual Meeting
Not Confirmed

01

AOCS Annual Meeting
Not Confirmed

GDUFA

DMF Review : N/A

Rev. Date :

Pay. Date :

DMF Number : 5590

Submission : 1984-10-24

Status : Inactive

Type : II

blank

02

AOCS Annual Meeting
Not Confirmed

02

AOCS Annual Meeting
Not Confirmed

GDUFA

DMF Review : N/A

Rev. Date :

Pay. Date :

DMF Number : 40265

Submission : 2025-10-24

Status : Active

Type : II

blank

03

AOCS Annual Meeting
Not Confirmed

03

AOCS Annual Meeting
Not Confirmed

GDUFA

DMF Review : N/A

Rev. Date :

Pay. Date :

DMF Number : 25466

Submission : 2011-10-31

Status : Active

Type : II

blank
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

JDMF

read-more
read-moreread-more

01

Arvo
Not Confirmed
arrow
arrow
Arvo
Not Confirmed

Japanese Pharmacopoeia Torperisone Hydrochloride

Registration Number : 217MF10876

Registrant's Address : 3-19-12 Kami-Ochiai, Shinjuku-ku, Tokyo

Initial Date of Registration : 2005-11-07

Latest Date of Registration : 2006-07-03

blank
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

EU WC

read-more
read-moreread-more

01

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothTranso-Pharm GmbH works globally to supply Active Pharmaceutical Ingredients adhering to the highest quality & GMP standards.

Flag Germany
Digital Content Digital Content

Tolperisone Hydrochloride

Date of Issue : 2022-02-22

Valid Till : 2026-12-31

Written Confirmation Number : TFDA-0002291

Address of the Firm : No. 168, Kai Yuan Rd, Hsin-Ying, Tainan City 73055, Taiwan

Transo Pharm Handels GmbH

02

Arvo
Not Confirmed
arrow
arrow
Arvo
Not Confirmed

Tolperisone Hydrochloride JP

Date of Issue : 2025-07-22

Valid Till : 2028-07-07

Written Confirmation Number : WC-0104

Address of the Firm : 124, 125 and 126, SIPCOT Industrial Complex, Hosur -635126, Tamil Nadu, India

blank

03

Arvo
Not Confirmed
arrow
arrow
Arvo
Not Confirmed

Tolperisone Hydrochloride IH

Date of Issue : 2025-08-01

Valid Till : 2028-07-02

Written Confirmation Number : WC-0112

Address of the Firm : Plot No. 69/A-2, GIDC Industrial Estate, Vapi, Dist

blank

04

Arvo
Not Confirmed
arrow
arrow
Arvo
Not Confirmed

Tolperisone Hydrochloride JP

Date of Issue : 2025-11-11

Valid Till : 2028-08-22

Written Confirmation Number : WC-0532

Address of the Firm : N-213/3, M.I.D.C. Tarapur, MIDC Tarapur Boisar, District: Thane-Zone4, Maharasht...

blank
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

Listed Suppliers

read-more
read-more

01

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothJai Radhe Sales is your partner for all your sourcing needs.

Flag India
Digital Content Digital Content

Tolperisone

About the Company : Jai Radhe Sales, founded in 1999, is a global distributor specializing in high-quality pharmaceutical ingredients from India. It offers complete sourcing solutions, technical and r...

Jai Radhe Sales, founded in 1999, is a global distributor specializing in high-quality pharmaceutical ingredients from India. It offers complete sourcing solutions, technical and regulatory support, and strives for global standards. Known for quality and affordability, it has established a niche through innovative methods and exports to nearly every continent. Note: Product(s) under patent(s) are offered only for R&D purposes as per the Patent Act & not for commercial sale.
Jai Radhe Sales

02

Arvo
Not Confirmed
arrow
arrow
Arvo
Not Confirmed

Tolperisone

About the Company : Aspire group was established in the year 2000 with a motto of quality drug for better health of all. In its journey till date, aspire has developed enormous reputation, consistent ...

Aspire group was established in the year 2000 with a motto of quality drug for better health of all. In its journey till date, aspire has developed enormous reputation, consistent growth, unique technologies and world class quality healthcare products. Aspire is pioneer in manufacturing and sourcing unique healthcare products. True to the statement, “Where the future started yesterday” with a foresight on the current trends in the healthcare market, Aspire has grown from strength combining its research strength, Human resources and well established quality systems. Aspire has crossed numerous milestones in a comparatively short period since its inception.
blank

03

Arvo
Not Confirmed
arrow
arrow
Arvo
Not Confirmed

Tolperisone

About the Company : SAI-TECH PHARMACEUTICALS PRIVATE LIMITED is dedicated Active Pharmaceutical Ingredients (API) manufacturing company for producing & providing high quality products as per customer ...

SAI-TECH PHARMACEUTICALS PRIVATE LIMITED is dedicated Active Pharmaceutical Ingredients (API) manufacturing company for producing & providing high quality products as per customer requirements. We tailor molecules according to customer requirements. The company is located in Navi Mumbai in the heart of India’s Industrial Area (i.e. TTC Industrial Area) from where best possible logistic support for R & D and other business transactions will takes place. We are ready to supply a product from gram to kilogram scale and from laboratory to pilot plant to large (commercial) scale production.
blank

04

Samhwa Biopharm

South Korea
Arvo
Not Confirmed
arrow

Samhwa Biopharm

South Korea
arrow
Arvo
Not Confirmed

Tolperisone

About the Company : Samhwa Biopharm Co., Ltd. is a South Korean pharmaceutical company specializing in the development and production of active pharmaceutical ingredients (APIs), excipients, and inter...

Samhwa Biopharm Co., Ltd. is a South Korean pharmaceutical company specializing in the development and production of active pharmaceutical ingredients (APIs), excipients, and intermediates. With a portfolio encompassing over 30 products, Samhwa Biopharm serves global markets, including Russia, Vietnam, and Colombia. The company operates manufacturing facilities in Gyeonggi-do, South Korea, and maintains a robust supply chain with partners in India. Samhwa Biopharm is committed to delivering high-quality pharmaceutical solutions to meet diverse therapeutic needs worldwide.
blank

05

Arvo
Not Confirmed
arrow
arrow
Arvo
Not Confirmed

Tolperisone Hydrochloride

About the Company : AOPHARM is a comprehensive manufacturer and an international distribution of chemicals throughout the world. Specialized in APIs, advanced intermediates, botanical extract & color ...

AOPHARM is a comprehensive manufacturer and an international distribution of chemicals throughout the world. Specialized in APIs, advanced intermediates, botanical extract & color industry. We aim to become leading position in global distribution & trading based on a rather unique combination of technical skill, unrivalled supplier network, market knowledge & an absolute commitment to customer satisfaction. Under a management team with professional experiences in chemical development, a pathbreaking optimization in our R&D center, advanced multi-purpose manufacturing facility and large-scale production bases with GMP.
blank

06

Arvo
Not Confirmed
arrow
arrow
Arvo
Not Confirmed

TOLPERISONE HCL

About the Company : Incorporated in 2011, SNA Health Care Pvt. Ltd., a WHO-GMP Certified API Manufacturing Company involved in the manufacture and export of Active Pharmaceutical Ingredients, Pharmace...

Incorporated in 2011, SNA Health Care Pvt. Ltd., a WHO-GMP Certified API Manufacturing Company involved in the manufacture and export of Active Pharmaceutical Ingredients, Pharmaceutical Excipients, and Drug Intermediates. They have recently forayed into the pharmaceutical domain, having been manufacturers of fine and specialty chemicals for two decades. It is a private limited company with its facility established in Mumbai.
blank

07

Arvo
Not Confirmed
arrow
arrow
Arvo
Not Confirmed

Tolperisone

About the Company : Xi’an Libang Enterprises, established in 1996, a hi-tech biopharmaceutical-oriented corporate group specialized in the development, production and distribution of pharmaceutical ...

Xi’an Libang Enterprises, established in 1996, a hi-tech biopharmaceutical-oriented corporate group specialized in the development, production and distribution of pharmaceutical products and healthy nutrition products, also presenting in the cultural industry. Libang Group, with Xi’an Libang Holdings Ltd. as the parent company, divided into Libang Pharmaceutical Group, Healthy Nutrition Group and other wholly owned subsidiaries engaged in culture, financial, property etc, totally over 1000 employees.
blank
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

Drugs in Development

read-more
read-more
  • Development Update

Details:

Tolperisone HCl is a drug candidate, which is currently being evaluated in phase III clinical studies for the treatment of Low Back Pain.


Lead Product(s): Tolperisone,Inapplicable

Therapeutic Area: Neurology Brand Name: Undisclosed

Study Phase: Phase IIIProduct Type: Undisclosed

Sponsor: National Research Development Fund, Hungary | Meditop Pharmaceutical

Deal Size: Inapplicable Upfront Cash: Inapplicable

Deal Type: Inapplicable September 16, 2022

blank

01

Semmelweis University

Country
arrow
AOCS Annual Meeting
Not Confirmed

Semmelweis University

Country
arrow
AOCS Annual Meeting
Not Confirmed

Lead Product(s) : Tolperisone,Inapplicable

Therapeutic Area : Neurology

Highest Development Status : Phase III

Partner/Sponsor/Collaborator : National Research Development Fund, Hungary | Meditop Pharmaceutical

Deal Size : Inapplicable

Deal Type : Inapplicable

Details : Tolperisone HCl is a drug candidate, which is currently being evaluated in phase III clinical studies for the treatment of Low Back Pain.

Product Name : Undisclosed

Product Type : Undisclosed

Upfront Cash : Inapplicable

September 16, 2022

blank

Details:

Phase 3, RESUME-1, clinical study of tolperisone for the relief of muscle spasm associated with acute, painful musculoskeletal conditions, failed to meet its primary and key secondary endpoints.


Lead Product(s): Tolperisone,Inapplicable

Therapeutic Area: Musculoskeletal Brand Name: Undisclosed

Study Phase: Phase IIIProduct Type: Miscellaneous

Sponsor: Undisclosed

Deal Size: Inapplicable Upfront Cash: Inapplicable

Deal Type: Inapplicable March 22, 2022

blank

02

AOCS Annual Meeting
Not Confirmed
AOCS Annual Meeting
Not Confirmed

Details : Phase 3, RESUME-1, clinical study of tolperisone for the relief of muscle spasm associated with acute, painful musculoskeletal conditions, failed to meet its primary and key secondary endpoints.

Product Name : Undisclosed

Product Type : Miscellaneous

Upfront Cash : Inapplicable

March 22, 2022

blank

Details:

Company completed its Phase 3 RESUME-1 Study of tolperisone for the relief of muscle spasm associated with acute, painful musculoskeletal conditions. The primary endpoint showed patient reported pain at day 14 due to acute back spasm.


Lead Product(s): Tolperisone,Inapplicable

Therapeutic Area: Musculoskeletal Brand Name: Undisclosed

Study Phase: Phase IIIProduct Type: Miscellaneous

Sponsor: Undisclosed

Deal Size: Inapplicable Upfront Cash: Inapplicable

Deal Type: Inapplicable November 29, 2021

blank

03

AOCS Annual Meeting
Not Confirmed
AOCS Annual Meeting
Not Confirmed

Details : Company completed its Phase 3 RESUME-1 Study of tolperisone for the relief of muscle spasm associated with acute, painful musculoskeletal conditions. The primary endpoint showed patient reported pain at day 14 due to acute back spasm.

Product Name : Undisclosed

Product Type : Miscellaneous

Upfront Cash : Inapplicable

November 29, 2021

blank

Details:

The scientific abstracts presented at both congresses demonstrate the potential benefit of tolperisone as a non-opioid, non-drowsy, non-central nervous system impairing skeletal muscle relaxant.


Lead Product(s): Tolperisone,Inapplicable

Therapeutic Area: Musculoskeletal Brand Name: Undisclosed

Study Phase: Approved FDFProduct Type: Miscellaneous

Sponsor: Undisclosed

Deal Size: Inapplicable Upfront Cash: Inapplicable

Deal Type: Inapplicable August 30, 2021

blank

04

AOCS Annual Meeting
Not Confirmed
AOCS Annual Meeting
Not Confirmed

Details : The scientific abstracts presented at both congresses demonstrate the potential benefit of tolperisone as a non-opioid, non-drowsy, non-central nervous system impairing skeletal muscle relaxant.

Product Name : Undisclosed

Product Type : Miscellaneous

Upfront Cash : Inapplicable

August 30, 2021

blank

Details:

Tolperisone HCl is a drug candidate, which is currently being evaluated in phase III clinical studies for the treatment of Back Pain.


Lead Product(s): Tolperisone,Inapplicable

Therapeutic Area: Neurology Brand Name: Undisclosed

Study Phase: Phase IIIProduct Type: Undisclosed

Sponsor: Undisclosed

Deal Size: Inapplicable Upfront Cash: Inapplicable

Deal Type: Inapplicable December 17, 2020

blank

05

AOCS Annual Meeting
Not Confirmed
AOCS Annual Meeting
Not Confirmed

Details : Tolperisone HCl is a drug candidate, which is currently being evaluated in phase III clinical studies for the treatment of Back Pain.

Product Name : Undisclosed

Product Type : Undisclosed

Upfront Cash : Inapplicable

December 17, 2020

blank

Details:

The published clinical data demonstrates the potential benefit of tolperisone in the treatment of acute and painful muscle spasms. The data supports and strengthens a planned Phase 3 RESUME-1 study, for which Neurana will begin enrollment imminently.


Lead Product(s): Tolperisone,Inapplicable

Therapeutic Area: Musculoskeletal Brand Name: Undisclosed

Study Phase: Phase IIIProduct Type: Miscellaneous

Sponsor: Undisclosed

Deal Size: Inapplicable Upfront Cash: Inapplicable

Deal Type: Inapplicable November 23, 2020

blank

06

AOCS Annual Meeting
Not Confirmed
AOCS Annual Meeting
Not Confirmed

Details : The published clinical data demonstrates the potential benefit of tolperisone in the treatment of acute and painful muscle spasms. The data supports and strengthens a planned Phase 3 RESUME-1 study, for which Neurana will begin enrollment imminently.

Product Name : Undisclosed

Product Type : Miscellaneous

Upfront Cash : Inapplicable

November 23, 2020

blank

Details:

The presentation will highlight results from a double-blind, randomized, placebo-controlled, multicenter phase 3 study evaluating Tolperisone 100 and 200 mg Three Times Daily (TID) for acute muscle spasm of the back.


Lead Product(s): Tolperisone,Inapplicable

Therapeutic Area: Musculoskeletal Brand Name: Undisclosed

Study Phase: Approved FDFProduct Type: Miscellaneous

Sponsor: Undisclosed

Deal Size: Inapplicable Upfront Cash: Inapplicable

Deal Type: Inapplicable September 02, 2020

blank

07

AOCS Annual Meeting
Not Confirmed
AOCS Annual Meeting
Not Confirmed

Details : The presentation will highlight results from a double-blind, randomized, placebo-controlled, multicenter phase 3 study evaluating Tolperisone 100 and 200 mg Three Times Daily (TID) for acute muscle spasm of the back.

Product Name : Undisclosed

Product Type : Miscellaneous

Upfront Cash : Inapplicable

September 02, 2020

blank

Details:

Tolperisone is a Other Small Molecule drug candidate, which is currently being evaluated in phase I clinical studies for the treatment of undefined medical condition.


Lead Product(s): Tolperisone,Inapplicable

Therapeutic Area: Undisclosed Brand Name: Undisclosed

Study Phase: Phase IProduct Type: Miscellaneous

Sponsor: Undisclosed

Deal Size: Inapplicable Upfront Cash: Inapplicable

Deal Type: Inapplicable July 10, 2020

blank

08

AOCS Annual Meeting
Not Confirmed
AOCS Annual Meeting
Not Confirmed

Details : Tolperisone is a Other Small Molecule drug candidate, which is currently being evaluated in phase I clinical studies for the treatment of undefined medical condition.

Product Name : Undisclosed

Product Type : Miscellaneous

Upfront Cash : Inapplicable

July 10, 2020

blank

Details:

The study is a randomized, 4-period, crossover study designed to investigate the effects of tolperisone on measures of drowsiness and cognitive function compared to cyclobenzaprine and placebo.


Lead Product(s): Tolperisone,Inapplicable

Therapeutic Area: Musculoskeletal Brand Name: Undisclosed

Study Phase: Phase IIProduct Type: Miscellaneous

Sponsor: Undisclosed

Deal Size: Inapplicable Upfront Cash: Inapplicable

Deal Type: Inapplicable June 08, 2020

blank

09

AOCS Annual Meeting
Not Confirmed
AOCS Annual Meeting
Not Confirmed

Details : The study is a randomized, 4-period, crossover study designed to investigate the effects of tolperisone on measures of drowsiness and cognitive function compared to cyclobenzaprine and placebo.

Product Name : Undisclosed

Product Type : Miscellaneous

Upfront Cash : Inapplicable

June 08, 2020

blank

Details:

Tolperisone HCl is a drug candidate, which is currently being evaluated in phase I clinical studies for the treatment of undefined medical condition.


Lead Product(s): Tolperisone,Inapplicable

Therapeutic Area: Undisclosed Brand Name: Undisclosed

Study Phase: Phase IProduct Type: Undisclosed

Sponsor: Undisclosed

Deal Size: Inapplicable Upfront Cash: Inapplicable

Deal Type: Inapplicable May 29, 2020

blank

10

AOCS Annual Meeting
Not Confirmed
AOCS Annual Meeting
Not Confirmed

Details : Tolperisone HCl is a drug candidate, which is currently being evaluated in phase I clinical studies for the treatment of undefined medical condition.

Product Name : Undisclosed

Product Type : Undisclosed

Upfront Cash : Inapplicable

May 29, 2020

blank
click full view
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

Digital Content read-more

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

Market Place

Do you need sourcing support? Ask us

REF. STANDARDS & IMPURITIES

Upload your portfolio for free, ask us

ANALYTICAL

Upload your methods for free, ask us

ABOUT THIS PAGE

Looking for 3644-61-9 / Tolperisone API manufacturers, exporters & distributors?

Tolperisone manufacturers, exporters & distributors 1

11

PharmaCompass offers a list of Tolperisone API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right Tolperisone manufacturer or Tolperisone supplier for your needs.

Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Tolperisone manufacturer or Tolperisone supplier.

API | Excipient name

Tolperisone

Synonyms

3644-61-9, Tolperisone hcl, Midocalm, Muscalm, Tolperisone (hydrochloride), 2,4'-dimethyl-3-piperidinopropiophenone hydrochloride

Cas Number

3644-61-9

Unique Ingredient Identifier (UNII)

8Z075K2TIG

About Tolperisone

A centrally acting muscle relaxant that has been used for the symptomatic treatment of spasticity and muscle spasm. (From Martindale, The Extra Pharmacopoeia, 30th ed, p1211)

Tolperisone Manufacturers

A Tolperisone manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Tolperisone, including repackagers and relabelers. The FDA regulates Tolperisone manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Tolperisone API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.

click here to find a list of Tolperisone manufacturers with USDMF, JDMF, KDMF, CEP, GMP, and COA related information on PhamaCompass.

Tolperisone Suppliers

A Tolperisone supplier is an individual or a company that provides Tolperisone active pharmaceutical ingredient (API) or Tolperisone finished formulations upon request. The Tolperisone suppliers may include Tolperisone API manufacturers, exporters, distributors and traders.

click here to find a list of Tolperisone suppliers with USDMF, JDMF, KDMF, CEP, GMP, and COA related information on PharmaCompass.

Tolperisone USDMF

A Tolperisone DMF (Drug Master File) is a document detailing the whole manufacturing process of Tolperisone active pharmaceutical ingredient (API) in detail. Different forms of Tolperisone DMFs exist exist since differing nations have different regulations, such as Tolperisone USDMF, ASMF (EDMF), JDMF, CDMF, etc.

A Tolperisone DMF submitted to regulatory agencies in the US is known as a USDMF. Tolperisone USDMF includes data on Tolperisone's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Tolperisone USDMF is kept confidential to protect the manufacturer’s intellectual property.

click here to find a list of Tolperisone suppliers with USDMF on PharmaCompass.

Tolperisone JDMF

The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.

The Tolperisone Drug Master File in Japan (Tolperisone JDMF) empowers Tolperisone API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).

PMDA reviews the Tolperisone JDMF during the approval evaluation for pharmaceutical products. At the time of Tolperisone JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.

click here to find a list of Tolperisone suppliers with JDMF on PharmaCompass.

Tolperisone WC

A Tolperisone written confirmation (Tolperisone WC) is an official document issued by a regulatory agency to a Tolperisone manufacturer, verifying that the manufacturing facility of a Tolperisone active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Tolperisone APIs or Tolperisone finished pharmaceutical products to another nation, regulatory agencies frequently require a Tolperisone WC (written confirmation) as part of the regulatory process.

click here to find a list of Tolperisone suppliers with Written Confirmation (WC) on PharmaCompass.

Tolperisone GMP

Tolperisone Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.

GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).

PharmaCompass offers a list of Tolperisone GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right Tolperisone GMP manufacturer or Tolperisone GMP API supplier for your needs.

Tolperisone CoA

A Tolperisone CoA (Certificate of Analysis) is a formal document that attests to Tolperisone's compliance with Tolperisone specifications and serves as a tool for batch-level quality control.

Tolperisone CoA mostly includes findings from lab analyses of a specific batch. For each Tolperisone CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.

Tolperisone may be tested according to a variety of international standards, such as European Pharmacopoeia (Tolperisone EP), Tolperisone JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Tolperisone USP).

Inform the supplier about your product requirements, specifying if you need a product with particular monograph like EP (Ph. Eur.), USP, JP, BP, or any other quality. In addition, clarify whether you need hydrochloride (HCl), anhydricum, base, micronisatum or a specific level of purity. To find reputable suppliers, utilize the filters and select those certified by GMP, FDA, or any other certification as per your requirement.
For your convenience, we have listed synonyms and CAS numbers to help you find the best supplier. The use of synonyms and CAS numbers can be helpful in identifying potential suppliers, but it is crucial to note that they might not always indicate the exact same product. It is important to confirm the product details with the supplier before making a purchase to ensure that it meets your requirements.
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty